The BRICS Neurovascular Catheters Market is projected to grow from US$ 605.7 million in 2024 to US$ 1,467.0 million by 2033, registering a CAGR of 10.3% during the forecast period from 2025 to 2033.
The BRICS region—including Brazil, Russia, India, China, South Africa, and the UAE—represents a high-growth neurovascular devices market, driven by rising stroke prevalence, increasing incidence of cerebral aneurysms, and expanding access to minimally invasive neurointerventional procedures. China leads the regional market, supported by high procedural volumes for mechanical thrombectomy and substantial investments in hospital infrastructure and domestic medical device manufacturing. Rapid urbanization, lifestyle-related risk factors, and aging populations across the region are further accelerating demand for catheter-based neurovascular interventions.
Hospitals in China, India, and Brazil are increasingly investing in advanced stroke care programs, expanding adoption of aspiration catheters, microcatheters, and coil delivery systems. Coated catheters are gaining traction due to infection-control requirements in tertiary care hospitals, while multi-lumen catheters are widely used in intensive care units for complex and simultaneous therapeutic administration. Hospitals and clinics remain the dominant end users, supported by rising procedural volumes, improved imaging infrastructure, and growing availability of neurointerventional specialists.
The competitive landscape includes multinational medical device manufacturers working in collaboration with regional distributors and local players to improve accessibility and cost efficiency. Strategic partnerships, localization strategies, and government-backed healthcare initiatives are key enablers of market penetration across diverse economic environments within BRICS countries.
Market Segmentation Overview
The BRICS Neurovascular Catheters Market is segmented by product type, coating type, lumen configuration, and end user.
By Product
The market includes thrombectomy catheters, embolization catheters, microcatheters, IVUS catheters, balloon catheters, and others. The thrombectomy catheter segment held the largest share in 2024, driven by its extensive use in acute ischemic stroke management.
By Coating Type
The market is divided into coated and uncoated catheters. Coated catheters dominated in 2024 due to their role in infection prevention and improved biocompatibility.
By Lumen
The segmentation includes single-lumen and multi-lumen catheters. Multi-lumen catheters led the market in 2024, supported by their ability to enable simultaneous therapy delivery in critical care environments.
By End User
Hospitals and clinics, diagnostic imaging centers, and others form the key segments. Hospitals and clinics accounted for the largest share in 2024, driven by increasing procedural capacity and expansion of stroke care infrastructure.
Key Market Driver: Rising Stroke and Aneurysm Burden
Stroke remains a leading cause of death and long-term disability globally, with ischemic stroke representing the majority of cases in BRICS countries. The burden is intensified by demographic aging, increasing prevalence of hypertension and diabetes, and lifestyle-related risk factors.
China, India, and Brazil account for a significant proportion of global stroke cases, resulting in high demand for emergency neurovascular interventions. Neurovascular catheters are critical in mechanical thrombectomy procedures, enabling clinicians to navigate complex cerebral anatomy, retrieve clots efficiently, and restore cerebral perfusion.
Cerebral aneurysms, often undetected until rupture, are increasingly diagnosed due to improved imaging capabilities, particularly in urban healthcare centers. Minimally invasive treatments such as coil embolization and flow diversion rely heavily on microcatheter systems for accurate device placement. Expanding investments in tertiary care infrastructure across BRICS nations are further supporting procedural growth and technology adoption.
Key Market Opportunity: Strategic Hospital–MedTech Collaborations
As neurovascular interventions become more advanced, hospitals across BRICS countries are increasingly partnering with medical technology companies to gain access to innovative catheter systems, clinical expertise, and procedural training.
These collaborations include co-development initiatives, long-term supply agreements, and clinical training programs designed to enhance physician proficiency and improve procedural outcomes. For manufacturers, such partnerships provide valuable insights into local clinical requirements, enabling development of catheters with improved flexibility, trackability, and performance across diverse anatomical profiles.
Hospitals benefit from early access to next-generation technologies, structured education programs, and improved procedural efficiency. Clinical collaborations also generate real-world evidence that supports regulatory approvals, guideline inclusion, and reimbursement expansion—particularly important in heterogeneous healthcare systems.
In emerging BRICS markets such as India and South Africa, these partnerships also help address infrastructure gaps, enhance device training, and support post-market clinical adoption. As healthcare systems increasingly emphasize value-based care and minimally invasive treatment pathways, such collaborations are expected to play a central role in accelerating market growth.
Country-Level Analysis
The BRICS Neurovascular Catheters Market spans China, India, Brazil, Russia, South Africa, and the UAE, with China holding the largest share in 2024.
China leads the regional market due to extensive healthcare infrastructure development, high neurovascular procedural volumes, and strong domestic manufacturing capabilities. India represents a high-volume, price-sensitive market driven by expanding tertiary care facilities and increasing stroke awareness. Brazil combines public and private healthcare systems, with growing adoption of advanced neurovascular technologies in urban hospitals.
Russia is gradually modernizing its healthcare infrastructure, improving access to advanced neurointerventional procedures in leading hospitals. South Africa is witnessing rising demand supported by increased neurological disease prevalence and expanding tertiary care capabilities. Across the region, hospitals and clinics remain the dominant end users due to higher procedural volumes and better access to interventional infrastructure.
Recent Industry Developments
In June 2025, Penumbra Inc. launched its SwiftSET neuro embolization coil system, designed to improve precision and control in aneurysm treatment, strengthening its presence across global markets, including BRICS countries.
In June 2025, Stryker introduced the AXS Lift intracranial base catheter, enhancing navigation and support during complex neurovascular procedures such as thrombectomy, particularly relevant for anatomically challenging cases in China and India.